- Bafetinib
-
- $2.00 / 1KG
-
2020-01-09
- CAS:887650-05-7
- Min. Order: 1g
- Purity: 98%min
- Supply Ability: ask
|
| Bafetinib Basic information |
Product Name: | Bafetinib | Synonyms: | (S)-N-(3-([5,5'-bipyriMidin]-2-ylaMino)-4-Methylphenyl)-4-((3-(diMethylaMino)pyrrolidin-1-yl)Methyl)-3-(trifluoroMethyl)benzaMide;bafetinib;N-[3-([5,5'-Bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)benzamide;Lyn-IN-1;Bafetinib, >=98%;(S)-N-(3-(5,5'-Bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)-pyrrolidin-1-yl)me;Bafetinib analog;Benzamide, N-[3-([5,5'-bipyrimidin]-2-ylamino)-4-methylphenyl]-4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)- | CAS: | 887650-05-7 | MF: | C30H31F3N8O | MW: | 576.62 | EINECS: | 1312995-182-4 | Product Categories: | APIs | Mol File: | 887650-05-7.mol | |
| Bafetinib Chemical Properties |
Melting point | >166°C (dec.) | density | 1.36 | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | solubility | DMSO, Methanol | form | Solid | color | Yellow |
| Bafetinib Usage And Synthesis |
Uses | A substituted benzamide derivative structurally related to STI-571 (Imatinib Mesylate). It was identified as highly potent Bcr-Abl kinase inhibitor. |
| Bafetinib Preparation Products And Raw materials |
|